Maja Razlog

MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors

Jonathan B. Fitzgerald, Bryan W. Johnson, Jason Baum et al. · Molecular Cancer Therapeutics · 2013 · 102 citations

Immunology, Tumor Biology, Insulin-like Growth Factor +17

A novel screening method to assess developability of antibody-like molecules

Neeraj Kohli, Melissa L. Geddie, Maja Razlog et al. · mAbs · 2015 · 76 citations · Full text

Immunocytochemical Technique, Engineering, Immunology +20

Antibody-mediated targeting of TNFR2 activates CD8 ⁺ T cells in mice and promotes antitumor immunity

Eric M. Tam, Ross B. Fulton, James F. Sampson et al. · Science Translational Medicine · 2019 · 56 citations · Full text

MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM

Jessica B. Casaletto, Melissa L. Geddie, Adnan O. Abu‐Yousif et al. · Proceedings of the National Academy of Sciences · 2019 · 30 citations · Full text

Rapid optimization and prototyping for therapeutic antibody-like molecules

Lihui Xu, Neeraj Kohli, Rachel Rennard et al. · mAbs · 2013 · 27 citations · Full text

Rapid Optimization, Systems Biology, Engineering +15